Category one submissions will be for medicines considered to have significant "added therapeutic value" - this categorisation system negotiated with the industry explicitly and objectively prioritises the needs of some patients over others. …
Latest Video
New Stories
-
Nominations open against a backdrop of change
September 16, 2019 - - Latest News -
Medicines Australia moves to broaden product focus
September 16, 2019 - - Latest News -
Venture capital leader warns against impact of government claims over research
September 16, 2019 - - Latest News -
Industry watching for the Final Budget Outcome
September 16, 2019 - - Latest News -
Boehringer Ingelheim funded grant for STROKE-AI project
September 16, 2019 - - Latest News -
Biotech leaders in Canberra to promote R&D investment
September 13, 2019 - - Latest News -
Industry 'hackles' over compassionate access pressure
September 13, 2019 - - Latest News